VALUE HEALTH ADDS $241 MIL IN NEW ACCOUNTS FOR 1994; VALUERx SUBSIDIARY IS NO LONGER FOR SALE; BERGEN BRUNSWIG FY 1994 SALES CLIMB 10% TO $7.5 BIL.
Value Health's specialty managed care benefit programs have added new customer accounts in 1994 representing $242 mil. in annual revenues, the company reported Nov. 3. For 1995, the company has "booked $137 mil. in new annualized revenues, which is 40% ahead of last year's growth at this time," Value Health said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth